- Home
- SNOA vs EFSH Comparison
SNOA vs EFSH Comparison
Compare SNOA & EFSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNOA
- EFSH
- Stock Information
- Founded
- SNOA 1999
- EFSH 1948
- Country
- SNOA United States
- EFSH United States
- Employees
- SNOA N/A
- EFSH N/A
- Industry
- SNOA Biotechnology: Pharmaceutical Preparations
- EFSH Professional Services
- Sector
- SNOA Health Care
- EFSH Consumer Discretionary
- Exchange
- SNOA Nasdaq
- EFSH Nasdaq
- Market Cap
- SNOA 3.6M
- EFSH 4.2M
- IPO Year
- SNOA 2007
- EFSH N/A
- Fundamental
- Price
- SNOA $2.40
- EFSH $0.15
- Analyst Decision
- SNOA
- EFSH
- Analyst Count
- SNOA 0
- EFSH 0
- Target Price
- SNOA N/A
- EFSH N/A
- AVG Volume (30 Days)
- SNOA 52.9K
- EFSH 2.7M
- Earning Date
- SNOA 02-05-2025
- EFSH 04-16-2025
- Dividend Yield
- SNOA N/A
- EFSH N/A
- EPS Growth
- SNOA N/A
- EFSH N/A
- EPS
- SNOA N/A
- EFSH N/A
- Revenue
- SNOA $13,973,000.00
- EFSH $69,415,140.00
- Revenue This Year
- SNOA $23.89
- EFSH N/A
- Revenue Next Year
- SNOA $25.45
- EFSH N/A
- P/E Ratio
- SNOA N/A
- EFSH N/A
- Revenue Growth
- SNOA 13.51
- EFSH 228.22
- 52 Week Low
- SNOA $2.30
- EFSH $0.15
- 52 Week High
- SNOA $9.40
- EFSH $717.62
- Technical
- Relative Strength Index (RSI)
- SNOA 36.06
- EFSH 38.07
- Support Level
- SNOA $2.30
- EFSH $0.15
- Resistance Level
- SNOA $2.62
- EFSH $0.17
- Average True Range (ATR)
- SNOA 0.12
- EFSH 0.02
- MACD
- SNOA -0.02
- EFSH 0.04
- Stochastic Oscillator
- SNOA 21.59
- EFSH 0.00
About SNOA Sonoma Pharmaceuticals Inc.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
About EFSH 1847 Holdings LLC
1847 Holdings LLC is a diversified holding company. It operates in Four segments: Retail and appliances, Retail and Eyewear, Construction, and Automotive Supplies. The company generates maximum revenue from the Construction segment. The firm, through its subsidiaries, provides a wide range of land application services and sells equipment and parts, primarily to the agricultural, construction, and lawn and garden industries.